Overall, our in vitro and in vivo models suggest that the prognostic NF-κB inflammatory signature in MM described in previous studies [9] is triggered by IL-1β on MSCs, which induce NF-κB activation in MM cells. Here, NFKB1 is linked to Miyoshi myopathy.